Comirnaty

News

New COVID-19 jabs approved by FDA for 2024-25 season

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in r

News

Pfizer/BioNTech COVID jab to be sold privately in UK

People in Great Britain will be able to buy the latest Omicron-directed version of Pfizer/BioNTech’s COVID-19 vaccine from retail pharmacies, starting in March.

News

Pfizer launches cost-cutting drive as COVID sales fall

Pfizer has said it will shed staff and cut its operating costs by around $3.5 billion, as it faces a shortfall in COVID-19 vaccine and treatment sales, with revenues now e

News

After COVID excess, Pfizer bracing for a hangover in 2023

Pfizer reaped the rewards of its COVID-19 vaccines and therapeutics in 2022, but there are already signs of falling demand that looks likely to get significantly worse in

News

Lawmakers accuse Pfizer of "pure greed" over COVID jab

Pfizer's decision to raise the price of its COVID-19 vaccine next year has prompted a rebuke from two Democrat senators in the US, who have accused the company of "unseemly profiteering."

News